These factors, which are often aberrantly expressed in DLBCL [50, 51], are known regulators of CENPE transcription [52, 53], and may serve as intermediaries in DDR1's effect on CENPE downregulation. The gene discussed is CENPE; the disease is diffuse large B-cell lymphoma.